FENOFIBRATE IMPROVES LIVER TESTS IN PRIMARY SCLEROSING CHOLANGITIS WITH INCOMPLETE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID

被引：0
|
作者：
Chazouilleres, Olivier [1 ,2 ]
Corpechot, Christophe [1 ,2 ]
Gaouar, Farid [1 ]
Poupon, Raoul [1 ,2 ]
机构：
[1] Hop St Antoine, APHP, Serv Hepatol, Ctr Reference Malad Inflammatoires Voies Biliaire, F-75571 Paris, France
[2] Univ Paris 06, Fac Med St Antoine, UMR S938, Paris, France
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
336
引用
收藏
页码：488A / 488A
页数：1
相关论文
共 50 条
  • [21] An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid
    Liu, Chung H.
    Yang, Guo-Xiang
    Johnson, Cole R.
    Dhaliwal, Sandeep S.
    Levy, Cynthia
    Peters, Marion G.
    Vierling, John M.
    Gershwin, M. Eric
    Bowlus, Christopher L.
    HEPATOLOGY, 2017, 66 : 160A - 160A
  • [22] Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
    Levy, C.
    Peter, J. A.
    Nelson, D. R.
    Keach, J.
    Petz, J.
    Cabrera, R.
    Clark, V.
    Firpi, R. J.
    Morelli, G.
    Soldevila-Pico, C.
    Lindor, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 235 - 242
  • [23] Primary sclerosing cholangitis: Conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid
    vonSchonfeld, J
    Zotz, R
    Mahl, M
    Beste, M
    Breuer, N
    Goebell, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (02): : 123 - 127
  • [24] Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol
    Ghonem, Nisanne S.
    Auclair, Adam M.
    Hemme, Christopher L.
    Gallucci, Gina M.
    de la Rosa Rodriguez, Randolph
    Boyer, James L.
    Assis, David N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1213 - 1223
  • [25] EFFECT OF URSODEOXYCHOLIC ACID WITHDRAWAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Wunsch, E.
    Trottier, J.
    Barbier, O.
    Milkiewicz, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S396 - S396
  • [26] Ursodeoxycholic acid to prevent colon cancer in primary sclerosing cholangitis
    Kowdley, KV
    CHOLESTATIC LIVER DISEASES: THERAPEUTIC OPTIONS AND PERSPECTIVES: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 136 : 323 - 332
  • [27] Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study
    Lindor, KD
    Jorgensen, RA
    Anderson, ML
    Gores, GJ
    Hofmann, AF
    LaRusso, NF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (03): : 511 - 515
  • [28] Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
    Triantos, C. K.
    Koukias, N. M.
    Nikolopoulou, V. N.
    Burroughs, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 901 - 910
  • [29] High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
    Silveira, Marina G.
    Lindor, Keith D.
    JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 692 - 694
  • [30] Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children
    Gilger, MA
    Gann, ME
    Opekun, AR
    Gleason, WA
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 31 (02): : 136 - 141
12345